Artificial Intelligence for Combating Antimicrobial Resistance: Recent Advances in Prediction, Surveillance, Drug Discovery, Antimicrobial Stewardship and Precision Therapy

Authors

Abstract

Objective: To review the role of artificial intelligence (AI) in addressing antimicrobial resistance (AMR), with a focus on its applications in antimicrobial resistance prediction, surveillance, antimicrobial drug discovery, and personalized antimicrobial therapy. Data Sources: A comprehensive literature search was conducted using electronic databases, including PubMed, Scopus, Google Scholar, and Web of Science, to identify relevant peer-reviewed articles on AI-driven approaches to AMR management. The search primarily covered publications from 2018 to 2026, supplemented by landmark studies and international reports published before 2018 to provide essential background information. Study Selection: Relevant peer-reviewed studies investigating the application of artificial intelligence, machine learning, and deep learning in AMR prediction, surveillance, drug discovery, and personalized antimicrobial therapy were selected. Studies were critically assessed for their relevance to the objectives of the review and their contribution to understanding the potential and limitations of AI-based AMR management. Summary of Content: Antimicrobial resistance is a major global public health challenge that reduces the effectiveness of antimicrobial therapy and contributes to increased morbidity, mortality, and healthcare costs. AI-driven approaches have demonstrated considerable potential in predicting antimicrobial resistance using genomic and clinical data, strengthening AMR surveillance, accelerating antimicrobial drug discovery, and supporting personalized treatment decisions. Unlike previous reviews focusing on individual AI applications, this review presents an integrated multidisciplinary perspective on AI-based AMR management. It also highlights key challenges, including data quality, model interpretability, generalizability, and the need for rigorous clinical validation before widespread implementation. Conclusion: Artificial intelligence offers promising opportunities to improve antimicrobial resistance prediction, surveillance, drug discovery, and personalized antimicrobial therapy. Integrating AI into antimicrobial stewardship and clinical decision-making may contribute to more effective AMR management. However, further validation, high-quality data, interpretable models, and prospective clinical studies are essential to establish the reliability, safety, and practical applicability of these approaches.

Keywords: Artificial intelligence; antimicrobial resistance; machine learning; antimicrobial stewardship; deep learning; precision therapy

Keywords:

Artificial intelligence, antimicrobial resistance, machine learning, drug discovery, precision medicine

DOI

https://doi.org/10.22270/jddt.v16i11.8081

Author Biography

Pooja Bagdi, Trinity Educational Institute, Ramgarh, Jharkhand, India

Trinity Educational Institute, Ramgarh, Jharkhand, India

References

1. Antimicrobial Resistance Collaborators, Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis, The Lancet, 2022;399(10325):629-655.

2. World Health Organization, Global action plan on antimicrobial resistance, World Health Organization, Geneva, 2015.

3. Price R, O’Neill report on antimicrobial resistance: Funding for antimicrobial specialists should be improved, European Journal of Hospital Pharmacy, 2016;23(4):245-247. https://doi.org/10.1136/ejhpharm-2016-001013

4. Holmes AH, Moore LSP, Sundsfjord A, et al., Understanding the mechanisms and drivers of antimicrobial resistance, The Lancet, 2016;387(10014):176-187. https://doi.org/10.1016/S0140-6736(15)00473-0

5. Anahtar MN, Yang JH, Kanjilal S, Applications of machine learning to the problem of antimicrobial resistance: An emerging model for translational research, Journal of Clinical Microbiology, 2021;59(7). https://doi.org/10.1128/JCM.01260-20

6. Arango-Argoty G, Garner E, Pruden A, Heath LS, Vikesland P, Zhang L, DeepARG: A deep learning approach for predicting antibiotic resistance genes from metagenomic data, Microbiome, 2018;6:23. https://doi.org/10.1186/s40168-018-0401-z

7. Boolchandani M, D’Souza AW, Dantas G, Sequencing-based methods and resources to study antimicrobial resistance, Nature Reviews Genetics, 2019;20:356-370. https://doi.org/10.1038/s41576-019-0108-4

8. Miotto R, Wang F, Wang S, Jiang X, Dudley JT, Deep learning for healthcare: Review, opportunities and challenges, Briefings in Bioinformatics, 2018;19(6):1236-1246. https://doi.org/10.1093/bib/bbx044

9. Topol EJ, High-performance medicine: The convergence of human and artificial intelligence, Nature Medicine, 2019;25:44-56. https://doi.org/10.1038/s41591-018-0300-7

10. Vamathevan J, Clark D, Czodrowski P, et al., Applications of machine learning in drug discovery and development, Nature Reviews Drug Discovery, 2019;18:463-477. https://doi.org/10.1038/s41573-019-0024-5

11. Stokes JM, Yang K, Swanson K, et al., A deep learning approach to antimicrobial discovery, Cell, 2020;180(4):688-702.e13. https://doi.org/10.1016/j.cell.2020.01.021

12. Ching T, Himmelstein DS, Beaulieu-Jones BK, et al., Opportunities and obstacles for deep learning in biology and medicine, Journal of the Royal Society Interface, 2018;15:20170387. https://doi.org/10.1098/rsif.2017.0387

13. Peiffer-Smadja N, Rawson TM, Ahmad R, et al., Machine learning for clinical decision support in infectious diseases: A systematic review, Clinical Microbiology and Infection, 2020;26(5):584-595. https://doi.org/10.1016/j.cmi.2019.09.009

14. Llor C, Bjerrum L, Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem, Therapeutic Advances in Drug Safety, 2014;5(6):229-241. https://doi.org/10.1177/2042098614554919

15. Van Belkum A, Bachmann TT, Lüdke G, et al., Developmental roadmap for antimicrobial susceptibility testing systems, Nature Reviews Microbiology, 2019;17:51-62. https://doi.org/10.1038/s41579-018-0098-9

16. Alkhanbouli R, Matar Abdulla Almadhaani H, Alhosani F, et al., The role of explainable artificial intelligence in disease prediction: A systematic literature review and future research directions, BMC Medical Informatics and Decision Making, 2025;25:110. https://doi.org/10.1186/s12911-025-02944-6

17. Bagdi P, Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India, Journal of Pharmacognosy and Phytochemistry, 2026;15(1):427-432. https://doi.org/10.22271/phyto.2026.v15.i1e.15756

18. Salama RA, Abdel Kader RG, Wadid NA, Artificial intelligence in combating challenges in antimicrobial resistance: A narrative review, Infection Prevention in Practice, 2026;8(2):100522. https://doi.org/10.1016/j.infpip.2026.100522

19. Bagdad Y, Miteva MA, Recent applications of artificial intelligence in discovery of new antibacterial agents, Advances and Applications in Bioinformatics and Chemistry, 2024;17:139-157. https://doi.org/10.2147/AABC.S484321

20. McGowan JE Jr, Gerding DN, Does antibiotic restriction prevent resistance? New Horizons, 1996;4:370-376.

21. Shlaes DM, Gerding DN, John JF, et al., Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee guidelines for the prevention of antimicrobial resistance in hospitals, Infection Control and Hospital Epidemiology, 1997;18:275-291. https://doi.org/10.2307/30141215

22. Dellit TH, Owens RC, McGowan JE, et al., Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship, Clinical Infectious Diseases, 2007;44:159-177. https://doi.org/10.1086/510393

23. Fishman N, Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS), Infection Control and Hospital Epidemiology, 2012;33:322-327. https://doi.org/10.1086/665010

24. Dyar OJ, Obua C, Chandy S, et al., Using antibiotics responsibly: Are we there yet? Future Microbiology, 2016;11:1057-1071. https://doi.org/10.2217/fmb-2016-0041

25. Tamma PD, Holmes A, Ashley ED, Antimicrobial stewardship, Current Opinion in Infectious Diseases, 2014;27:348-355. https://doi.org/10.1097/QCO.0000000000000077

26. Hulscher M, Prins J, Antibiotic stewardship: Does it work in hospital practice? A review of the evidence base, Clinical Microbiology and Infection, 2017;23:799-805. https://doi.org/10.1016/j.cmi.2017.07.017

27. Barlam TF, Cosgrove SE, Abbo LM, et al., Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America, Clinical Infectious Diseases, 2016;62-e77. https://doi.org/10.1093/cid/ciw118

28. Dyar OJ, Tebano G, Pulcini C, Managing responsible antimicrobial use: Perspectives across the healthcare system, Clinical Microbiology and Infection, 2017;23:441-447. https://doi.org/10.1016/j.cmi.2017.04.016

29. Aryee A, Price N, Antimicrobial stewardship-can we afford to do without it? British Journal of Clinical Pharmacology, 2015;79:173-181. https://doi.org/10.1111/bcp.12417

30. Chowdhury AS, Lofgren ET, Moehring RW, Broschat SL, Identifying predictors of antimicrobial exposure in hospitalized patients using a machine learning approach, Journal of Applied Microbiology, 2020;128(3):688-696. https://doi.org/10.1111/jam.14499

31. Moehring RW, Phelan M, Lofgren E, Nelson A, Dodds Ashley E, Anderson DJ, Goldstein BA, Development of a machine learning model using electronic health record data to identify antibiotic use among hospitalized patients, JAMA Network Open, 2021;4(3). https://doi.org/10.1001/jamanetworkopen.2021.3460

32. Goodman KE, Heil EL, Claeys KC, Banoub M, Bork JT, Real-world antimicrobial stewardship experience in a large academic medical center: Using statistical and machine learning approaches to identify intervention hotspots in an antibiotic audit and feedback program, Open Forum Infectious Diseases, 2022;9(7). https://doi.org/10.1093/ofid/ofac289

33. Mancini A, Vito L, Marcelli E, Piangerelli M, De Leone R, Pucciarelli S, Merelli E, Machine learning models predicting multidrug resistant urinary tract infections using “DsaaS”, BMC Bioinformatics, 2020;21(Suppl 10):347. https://doi.org/10.1186/s12859-020-03566-7

34. Wong JG, Aung AH, Lian W, Lye DC, Ooi CK, Chow A, Risk prediction models to guide antibiotic prescribing: A study on adult patients with uncomplicated upper respiratory tract infections in an emergency department, Antimicrobial Resistance and Infection Control, 2020;9(1):171. https://doi.org/10.1186/s13756-020-00825-3

35. Kanjilal S, Oberst M, Boominathan S, Zhou H, Hooper DC, Sontag D, A decision algorithm to promote outpatient antimicrobial stewardship for uncomplicated urinary tract infection, Science Translational Medicine, 2020;12(568). https://doi.org/10.1126/scitranslmed.aay5067

36. Tang R, Luo R, Tang S, Song H, Chen X, Machine learning in predicting antimicrobial resistance: A systematic review and meta-analysis, International Journal of Antimicrobial Agents, 2022;60(5-6):106684. https://doi.org/10.1016/j.ijantimicag.2022.106684

37. Greenhalgh T, Wherton J, Papoutsi C, et al., Beyond adoption: A new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies, Journal of Medical Internet Research, 2017;19(11). https://doi.org/10.2196/jmir.8775

38. Liyanage H, Liaw ST, Jonnagaddala J, Schreiber R, Kuziemsky C, Terry AL, de Lusignan S, Artificial intelligence in primary health care: Perceptions, issues, and challenges, Yearbook of Medical Informatics, 2019;28(1):41-46. https://doi.org/10.1055/s-0039-1677901

39. Beil M, Proft I, van Heerden D, Sviri S, van Heerden PV, Ethical considerations about artificial intelligence for prognostication in intensive care, Intensive Care Medicine Experimental, 2019;7(1):70. https://doi.org/10.1186/s40635-019-0286-6

40. Gianfrancesco MA, Tamang S, Yazdany J, Schmajuk G, Potential biases in machine learning algorithms using electronic health record data, JAMA Internal Medicine, 2018;178(11):1544-1547. https://doi.org/10.1001/jamainternmed.2018.3763

41. Abdullah YI, Schuman JS, Shabsigh R, Caplan A, Al-Aswad LA, Ethics of artificial intelligence in medicine and ophthalmology, Asia-Pacific Journal of Ophthalmology, 2021;10(3):289-298. https://doi.org/10.1097/APO.0000000000000397

42. Yang K, Swanson K, Jin W, et al., Analyzing learned molecular representations for property prediction, Journal of Chemical Information and Modeling, 2019;59(8):3370-3388. https://doi.org/10.1021/acs.jcim.9b00237

43. Liu G, Catacutan DB, Rathod K, et al., Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii, Nature Chemical Biology, 2023;19:1342-1350. https://doi.org/10.1038/s41589-023-01349-8

44. Rahman ASMZ, Liu C, Sturm H, et al., A machine learning model trained on a high-throughput antibacterial screen increases the hit rate of drug discovery, PLoS Computational Biology, 2022;18. https://doi.org/10.1371/journal.pcbi.1010613

45. Olayo-Alarcón R, Amstalden MK, Zannoni A, et al., Pre-trained molecular representations enable antimicrobial discovery, Nature Communications, 2025;16:3420. https://doi.org/10.1038/s41467-025-58804-4

46. Boudza R, Bounou S, Segura-Garcia J, Moukadiri I, Maicas S, Artificial intelligence as a catalyst for antimicrobial discovery: From predictive models to de novo design, Microorganisms, 2026;14(2):394. https://doi.org/10.3390/microorganisms14020394

47. Lewin-Epstein O, Baruch S, Hadany L, Stein GY, Obolski U, Predicting antibiotic resistance in hospitalized patients by applying machine learning to electronic medical records, Clinical Infectious Diseases, 2021;72(11)-e855. https://doi.org/10.1093/cid/ciaa1576

48. Valavarasu S, Sangu Y, Mahapatra T, Prediction of antibiotic resistance from antibiotic susceptibility testing results from surveillance data using machine learning, Scientific Reports, 2025;15:30509. https://doi.org/10.1038/s41598-025-14078-w

49. Talamantes-Becerra B, Wickramarachchi A, Bauer DC, Sng L, Nguyen A, Twine N, Leroux H, Prediction of antibiotic susceptibility in E. coli isolates using machine learning, Studies in Health Technology and Informatics, 2024;318:150-155. https://doi.org/10.3233/SHTI240907

50. Wang WY, Chiu CF, Tsao SM, Lee YL, Chen YH, Accurate prediction of antimicrobial resistance and genetic marker of Staphylococcus aureus clinical isolates using MALDI-TOF MS and machine learning across DRIAMS and Taiwan database, International Journal of Antimicrobial Agents, 2024;64(5):107329. https://doi.org/10.1016/j.ijantimicag.2024.107329

51. Yuan K, Luk A, Wei J, Walker AS, Zhu T, Eyre DW, Machine learning and clinician predictions of antibiotic resistance in Enterobacterales bloodstream infections, Journal of Infection, 2025;90(2):106388. https://doi.org/10.1016/j.jinf.2024.106388

52. Ali T, Ahmed S, Aslam M, Artificial intelligence for antimicrobial resistance prediction: Challenges and opportunities towards practical implementation, Antibiotics, 2023;12(3):523. https://doi.org/10.3390/antibiotics12030523

Published

2026-11-15
Statistics
Abstract Display: 0
PDF Downloads: 0
PDF Downloads: 0

How to Cite

1.
Bagdi P. Artificial Intelligence for Combating Antimicrobial Resistance: Recent Advances in Prediction, Surveillance, Drug Discovery, Antimicrobial Stewardship and Precision Therapy. J. Drug Delivery Ther. [Internet]. 2026 Nov. 15 [cited 2026 Nov. 16];16(11):158-69. Available from: https://jddtonline.info/index.php/jddt/article/view/8081

How to Cite

1.
Bagdi P. Artificial Intelligence for Combating Antimicrobial Resistance: Recent Advances in Prediction, Surveillance, Drug Discovery, Antimicrobial Stewardship and Precision Therapy. J. Drug Delivery Ther. [Internet]. 2026 Nov. 15 [cited 2026 Nov. 16];16(11):158-69. Available from: https://jddtonline.info/index.php/jddt/article/view/8081